Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 33.3% decrease from the number of companies cited in the previous quarter.
The citations in the county include:
- You did not establish and maintain procedures for testing, screening and determining the eligibility of HCT/P donors.
- The summary of records for HCT/Ps did not contain a listing and an interpretation of results of all communicable disease tests performed.
- Donors were not screened by a review of relevant medical records for risk factors of communicable disease agents and diseases.
Both companies cited were involved in either Biologics or Drugs sectors.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Micra Biotechnologies, Inc. | Drugs | 08/02/2024 | Procedures not in writing, fully followed |
Micra Biotechnologies, Inc. | Drugs | 08/02/2024 | GMP Training Frequency |
Micra Biotechnologies, Inc. | Drugs | 08/02/2024 | Control / Lab Operations Area |
Micra Biotechnologies, Inc. | Drugs | 08/02/2024 | Following/documenting laboratory controls |
Micra Biotechnologies, Inc. | Drugs | 08/02/2024 | Scientifically sound laboratory controls |
North Hudson IVF Center for Fertility & Gynecology, P.C. | Biologics | 07/02/2024 | Testing, screening, donor eligibility procedures |
North Hudson IVF Center for Fertility & Gynecology, P.C. | Biologics | 07/02/2024 | Listing and interpretation of CD tests performed |
North Hudson IVF Center for Fertility & Gynecology, P.C. | Biologics | 07/02/2024 | Risk factors, clinical evidence |